Paul Hudson, Sanofi CEO (Sipa via AP Images)
Sanofi continuing with API spinoff despite French on-shoring push, tensions with union — Reuters
The question of where and by whom drugs’ active ingredients are manufactured was a fairly niche issue back in February, when new Sanofi CEO Paul …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
